These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 19998195)
1. Placebo misconceptions. Senn S Am J Bioeth; 2009 Sep; 9(9):53-4. PubMed ID: 19998195 [No Abstract] [Full Text] [Related]
2. A clinical perspective on placebo research: looking back, looking forward. Dworkin RW Am J Bioeth; 2009 Sep; 9(9):54-5. PubMed ID: 19998196 [No Abstract] [Full Text] [Related]
3. Preparing for a post-placebo paradigm: ethics and choice of control in clinical trials. Nunn R Am J Bioeth; 2009 Sep; 9(9):51-2. PubMed ID: 19998194 [No Abstract] [Full Text] [Related]
4. Research, medicine, and "placebos". Moerman DE Am J Bioeth; 2009 Sep; 9(9):64-5. PubMed ID: 19998201 [No Abstract] [Full Text] [Related]
5. Questioning the methodologic superiority of 'placebo' over 'active' controlled trials. Howick J Am J Bioeth; 2009 Sep; 9(9):34-48. PubMed ID: 19998192 [TBL] [Abstract][Full Text] [Related]
6. Conflating scientific with clinical considerations. van der Graaf R; van Delden JJ Am J Bioeth; 2009 Sep; 9(9):58-9. PubMed ID: 19998198 [No Abstract] [Full Text] [Related]
7. The rationale for placebo-controlled trials: methodology and policy considerations. Miller FG Am J Bioeth; 2009 Sep; 9(9):49-50. PubMed ID: 19998193 [No Abstract] [Full Text] [Related]
8. Who's in control of the choice of control? Anderson JA Am J Bioeth; 2009 Sep; 9(9):60-2. PubMed ID: 19998199 [No Abstract] [Full Text] [Related]
9. Ethical issues in the difference between placebo-controlled and active-controlled trials. Petrini C Am J Bioeth; 2009 Sep; 9(9):56-8. PubMed ID: 19998197 [No Abstract] [Full Text] [Related]
10. Strengthening Howick's argument against the alleged superiority of placebo-controlled trials. Rennie S; Stürmer T Am J Bioeth; 2009 Sep; 9(9):62-4. PubMed ID: 19998200 [No Abstract] [Full Text] [Related]
11. Control theory: placebo-controlled drug trials have problems. Active-controlled drug trials are not always the solution. Golomb BA Am J Bioeth; 2009 Sep; 9(9):67-9. PubMed ID: 19998203 [No Abstract] [Full Text] [Related]
12. Reviewing the unsubstantiated claims for the methodological superiority of 'placebo' over 'active' controlled trials: reply to open peer commentaries. Howick J Am J Bioeth; 2009 Sep; 9(9):W5-7. PubMed ID: 19998178 [No Abstract] [Full Text] [Related]
13. Innovation and placebos in research: a new design of clinical trial. Holbrook A; Goldsmith C Lancet; 2003 Dec; 362(9401):2036-7. PubMed ID: 14697799 [No Abstract] [Full Text] [Related]
14. Questioning the methodological superiority of 'placebo' over 'active' controlled trials. Enkin MW Am J Bioeth; 2009 Sep; 9(9):66-7. PubMed ID: 19998202 [No Abstract] [Full Text] [Related]
15. Placebo. McQuay HJ; Moore RA Postgrad Med J; 2005 Mar; 81(953):155-60. PubMed ID: 15749790 [TBL] [Abstract][Full Text] [Related]
16. Exploitation and the ethics of clinical trials. Resnik DB Am J Bioeth; 2002; 2(2):28-30. PubMed ID: 12189070 [No Abstract] [Full Text] [Related]
17. [Contemporary concept of placebo usage in clinical trials of new drugs]. Orzechowska-Juzwenko K Pol Merkur Lekarski; 2007 Dec; 23(138):473-7. PubMed ID: 18432136 [TBL] [Abstract][Full Text] [Related]
19. Distinguishing dilemmas in the ethics of placebo-controlled trials. Kovach K Am J Bioeth; 2002; 2(2):32-3. PubMed ID: 12189072 [No Abstract] [Full Text] [Related]